drugset / Trial / NCT03121638
Safety Study of NBP608 in Healthy Adult Volunteers
Non-randomizedParallel-groupOpen-labelPrevention
Summary
* Indication: Protection against varicella and herpes zoster * Study Objectives * Primary: Safety and tolerability assessment after single dose administration of NBP608 * Secondary: immunogenicity assessment after single dose administration of NBP608
Timeline
- Start
- 2012-11
- Primary completion
- 2013-02
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NBP6081 | Unknown | 0.5 ml | Subcutaneous |
| Subject | NBP6082 | Unknown | 0.5 ml | Subcutaneous |
| Subject | NBP6083 | Unknown | 0.5 ml | Subcutaneous |
| Comparator | Varivax | Vaccine | 0.5 ml | Subcutaneous |
| Comparator | Varivax | Vaccine | 0.65 ml | Subcutaneous |